Literature DB >> 7532422

Significance of increased neutrophils in patients with advanced colorectal cancer.

A Satomi1, S Murakami, K Ishida, M Mastuki, T Hashimoto, M Sonoda.   

Abstract

We examined the ratio of neutrophils to lymphocytes (N/L ratio) in the peripheral blood in patients with colorectal cancer. The ability to produce active oxygen and phagocytosis of neutrophils, G-CSF, sIL-2R and IAP (immunosuppressive acidic protein) were also measured. The N/L ratios were significantly higher in the advanced stages of cancer than in normal controls. The ability to produce active oxygen in the terminal stage was 33% lower than in the control group. The G-CSF levels had no relationship with the neutrophil counts. IAP levels increased with cancer stage, and were inversely related to the ability to produce active oxygen. The IAP levels correlated well with the sIL-2R levels and the N/L ratio. These findings suggest that the ability to produce active oxygen, N/L ratio and IAP reflect anticancer mechanisms and that they may be useful when considering treatment or prognosis of patients with advanced stages of cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532422     DOI: 10.3109/02841869509093641

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  37 in total

1.  The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer.

Authors:  Jin-Seong Cho; Min-Ho Park; Young-Jae Ryu; Jung-Han Yoon
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

2.  Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation.

Authors:  Tian-Hui Yang; Lisa S St John; Haven R Garber; Celine Kerros; Kathryn E Ruisaard; Karen Clise-Dwyer; Gheath Alatrash; Qing Ma; Jeffrey J Molldrem
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

3.  Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.

Authors:  Keisuke Kosumi; Yoshifumi Baba; Takatsugu Ishimoto; Kazuto Harada; Kenichi Nakamura; Mayuko Ohuchi; Yuki Kiyozumi; Daisuke Izumi; Ryuma Tokunaga; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Junji Kurashige; Yukiharu Hiyoshi; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2015-06-03       Impact factor: 2.549

4.  Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.

Authors:  Long Jiang; Zerui Zhao; Shanshan Jiang; Yongbin Lin; Han Yang; Zehua Xie; Yaobin Lin; Hao Long
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

5.  Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer.

Authors:  In Rae Cho; Jun Chul Park; Chan Hyuk Park; Jung Hyun Jo; Hyun Jik Lee; Sunyong Kim; Choong Nam Shim; Hyuk Lee; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Gastric Cancer       Date:  2014-01-19       Impact factor: 7.370

6.  Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer.

Authors:  Masaki Aizawa; Naoto Gotohda; Shinichiro Takahashi; Masaru Konishi; Taira Kinoshita
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

7.  Prediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancer.

Authors:  Huanran Liu; Mingzhi Song; Fengqi Fang; Xue Gao; Zhen Zhang; Shouyu Wang
Journal:  Oncol Lett       Date:  2015-08-04       Impact factor: 2.967

8.  Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer.

Authors:  Tian-Geng You; Hong-Shun Wang; Jia-He Yang; Qi-Jun Qian; Rui-Fang Fan; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

9.  The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

Authors:  Shouyu Wang; Zhen Zhang; Fengqi Fang; Xue Gao; Wei Sun; Huanran Liu
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

10.  An epigenetic signature in peripheral blood predicts active ovarian cancer.

Authors:  Andrew E Teschendorff; Usha Menon; Aleksandra Gentry-Maharaj; Susan J Ramus; Simon A Gayther; Sophia Apostolidou; Allison Jones; Matthias Lechner; Stephan Beck; Ian J Jacobs; Martin Widschwendter
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.